Christophe Ghysel, Christophe

dr. Christophe Ghysel

Urologie

106PElevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer.

Annals of Oncology. 2019 Oct 1;30 (Supplement_5).
01/10/2019

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer.

JAMA Oncol. 2019 Jul 1;5(7):1060–2.
01/07/2019